GRN and Alzheimer disease: Previous studies have demonstrated that PGRN deficiency promotes Aβ deposition, and overexpression of PGRN reduced Aβ plaque burden in several AD transgenic mouse models (Minami et al., 2014; Van Kampen and Kay, 2017).